LOS ANGELES, Calif., May 16, 2018 /PRNewswire/ -- New Zealand-based nutrition and e-commerce company calocurb today announced the launch of its 100% plant-based, non-GMO weight management supplement, clinically shown to reduce calorie intake by around 20% during meal and snack times.
Made from just three ingredients, a New Zealand hops flower extract, rosemary leaf and canola oil, calocurb is the world's first consumer product to activate 'the bitter brakeTM' - a natural, evolutionary mechanism that creates a feeling of fullness or satiety.
Designed to help manage food cravings and support portion control, calocurb is available now at https://calo-curb.com on a subscription basis at a cost of $49.95 for a one-month supply.
The active ingredient in calocurb is Amarasate®, an extract derived from a specific variety of hops flower sourced from New Zealand.
The appetite management properties of Amarasate are backed by science. Developed by New Zealand's Plant & Food Research institute over a six-year project, the extract was found to be the most effective compound (out of more than 900 plants screened) to trigger 'the bitter brake' – an evolutionary response whereby bitter compounds trigger a 'stop eating' signal in the brain.
When coupled with patented capsule technology, calocurb progressed through clinical trials to demonstrate significant calorie intake reduction over measured meals and snacks.
"calocurb is a game-changer when it comes to healthy, sustainable weight management. While there are no magic pills out there, we do believe our product helps people to feel confident and in control of their food choices -- especially with obesity and overweight at epidemic proportions around the world," says calocurb CEO Sarah Kennedy, a 25-year veteran in the health and wellness industry.
"Most weight management supplements fall under three types - fillers, metabolic stimulants and laxatives. Calocurb sits apart from these and represents a real breakthrough in the category. It curbs appetite, overeating and hunger management without the usual negative side effects of twitchiness and bloating associated with other products."
Launched in New Zealand in early April, calocurb saw widespread news coverage including primetime TV news and the cover story of investigative magazine North & South "The End of Overeating: Have NZ Scientists finally found a pill that controls hunger?"
Designed to be used in conjunction with a healthy diet and fitness regime, calocurb is a simple tool for supporting healthy weight management.
As instructed on the label, the only guidelines are to take one capsule an hour before meals or snacks and no more than two capsules a day.
calocurb is not intended for use by anyone under 18 years of age, or for pregnant or breastfeeding women. As with any dietary supplement, customers should consult their healthcare provider before using calocurb, especially those with a medical condition, who are taking medications, or have known adverse reactions or allergies.
About calocurb
calocurbTM is a 100% plant-based weight management designed to help manage food cravings and support portion control at meal times. A world first and a breakthrough product in the weight management category, calocurb's active ingredient is a specific New Zealand-grown hop flower extract - Amarasate® - developed by Plant & Food Research, New Zealand's largest Crown Research Institute. In clinical trials, calocurb was shown to reduce calorie intake by around 20% at meal or snack time. calocurb is licensed and commercialized by calocurb Ltd – a new company specializing in nutrition and e-commerce.
Customers are also reminded to always read the label and use as directed. Weight management products like calocurb should be used in conjunction with a balanced diet and exercise.
For more information on calocurb, please visit https://calo-curb.com or contact Kelly Vogt Campbell at [email protected] or (310) 927-4537.
SOURCE calocurb
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article